
Psilocybin (Magic Mushrooms) | National Institute on Drug Abuse
2024年1月24日 · Psilocin activity at the 5HT2a receptor affects how the brain works and how different brain regions communicate with each other. These altered patterns of brain activity contribute to a person’s profound change in consciousness.
Law enforcement seizures of psilocybin mushrooms rose …
2024年2月6日 · Law enforcement seizures of “magic mushrooms” or “shrooms” containing the psychoactive component psilocybin increased dramatically in the United States between January 2017 and December 2022, according to a new study funded by the National Institute on Drug Abuse, part of the National Institutes of Health.
La psilocibina (setas u hongos mágicos) - National Institute on …
2024年1月24日 · Cuando una persona toma psilocibina, su cuerpo la convierte en otra sustancia, la psilocina. La psilocina se une y activa los receptores, o sitios de unión, para la serotonina química del cerebro, principalmente el receptor de serotonina 5-hidroxitriptamina 2A (5HT2a).
HALLUCINOGENS AND DISSOCIATIVE DRUGS Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, PCP, Ketamine, Dextromethorphan, and Salvia
HALLUCINOGENS AND DISSOCIATIVE DRUGS Including LSD, PCP, Ketamine, Psilocybin, Salvia, Peyote, and Dextromethorphan
Psychedelic and Dissociative Drugs | National Institute on Drug …
2024年8月29日 · Psychedelic and dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions of reality. 1 Among other health effects and safety concerns, people who use psychedelic and dissociative drugs report feeling strong emotions, ranging from intense happiness and a feeling of connectedness to fear, anxiety, and confusion. 2,3 People who use these drugs also report experiencing ...
Psychedelic and Dissociative Drugs as Medicines
2024年1月24日 · Technology such as brain imaging expanded scientists’ capacity to study psychedelic and dissociative drugs in the laboratory, stimulating a new wave of research in the early 1990s. 3 Today, they are studying many of these substances to determine their potential therapeutic effects, along with appropriate dosages and the best way to deliver corresponding treatments, such as talk therapy. 4 ...
Xylazine | National Institute on Drug Abuse (NIDA)
2025年1月8日 · Xylazine is a tranquilizer, pain reliever, and central nervous system depressant that is U.S. Food and Drug Administration (FDA)-approved for use in veterinary medicine.
National Institute on Drug Abuse Intramural Research Program
The National Institute on Drug Abuse Intramural Research Program is a research facility in Baltimore, MD. The NIDA IRP dedicated to understanding the causes, consequences and treatment of drug abuse.
Demystifying Medicine - National Institute on Drug Abuse (NIDA)
2024年4月23日 · The Demystifying Medicine Series, jointly sponsored by FAES and NIH, includes presentations on pathology, diagnosis, and therapy in the context of major disease problems and current research.